These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmaceuticals and medical devices: cost savings. Steiner DJ Issue Brief Health Policy Track Serv; 2013 Dec; ():1-32. PubMed ID: 24482891 [No Abstract] [Full Text] [Related]
3. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha. 't Hoen E Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298 [No Abstract] [Full Text] [Related]
4. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief. Health Policy Tracking Service, A Service of Thomson Reuters/West Issue Brief Health Policy Track Serv; 2011 Jan; ():1-21. PubMed ID: 21374837 [No Abstract] [Full Text] [Related]
5. Patents, pills and politics: the Australia-United States Free Trade Agreement and the Pharmaceutical Benefits Scheme. Harvey K Aust Health Rev; 2004 Nov; 28(2):218-26. PubMed ID: 15527402 [TBL] [Abstract][Full Text] [Related]
6. Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere. Baker BK PLoS Med; 2016 Mar; 13(3):e1001970. PubMed ID: 26954325 [TBL] [Abstract][Full Text] [Related]
7. The Problem of Limited-Supply Agreements for Medicare Price Negotiation. Gabriele SME; Feldman WB JAMA; 2023 Oct; 330(13):1223-1224. PubMed ID: 37713185 [TBL] [Abstract][Full Text] [Related]
8. Pharmaceuticals and medical devices: cost savings. Issue brief. Steiner DJ Issue Brief Health Policy Track Serv; 2012 Dec; ():1-33. PubMed ID: 23297446 [No Abstract] [Full Text] [Related]
9. Australia-United States Free Trade Agreement and the Australian Pharmaceutical Benefits Scheme. Sainsbury P Yale J Health Policy Law Ethics; 2004; 4(2):387-99. PubMed ID: 15536920 [No Abstract] [Full Text] [Related]
10. Generics industry and doctors nervous over free trade deal. Burton B BMJ; 2004 May; 328(7449):1158. PubMed ID: 15142916 [No Abstract] [Full Text] [Related]
11. Pharmaceuticals and medical devices: cost savings. ; Steiner DJ Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843 [No Abstract] [Full Text] [Related]
12. Australia amends its free trade deal with US to lessen effect on drug costs. Burton B BMJ; 2004 Aug; 329(7463):420. PubMed ID: 15321891 [No Abstract] [Full Text] [Related]
13. TRIPS AGREEMENT ARTICLE 31(B): THE NEED FOR REVISION. Effingham AM Seton Hall Law Rev; 2016; 46(3):883-909. PubMed ID: 27066613 [No Abstract] [Full Text] [Related]
14. USA pressured to ease trade demands. Ahmad K Lancet; 2004 Mar; 363(9411):790. PubMed ID: 15022641 [No Abstract] [Full Text] [Related]
15. Pharmaceuticals and medical devices: business practices. Steiner DJ Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889 [No Abstract] [Full Text] [Related]
16. Australian drug pricing scheme under pressure in free trade talks. Burton B BMJ; 2004 Jan; 328(7434):247. PubMed ID: 14751890 [No Abstract] [Full Text] [Related]
17. World Trade Organization still threatens supply of affordable AIDS drugs. Hagmann M Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300 [No Abstract] [Full Text] [Related]
18. Pharmaceuticals and medical devices: business practices. ; Steiner DJ Issue Brief Health Policy Track Serv; 2012 Jan; ():1-35. PubMed ID: 22423396 [No Abstract] [Full Text] [Related]
19. Australian pharmaceutical policy: price control, equity, and drug innovation in Australia. Doran E; Alexander Henry D J Public Health Policy; 2008 Apr; 29(1):106-20. PubMed ID: 18368023 [TBL] [Abstract][Full Text] [Related]